chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Skin discolouration, Vaccination site pain, Vaccination site pruritus
Clinical narrative: Weak; Legs could not carry her; Looks like a sunburn; Rash; Itchy vaccine arm; Pain on the injection arm; Painful joints; Shooting pain in head; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Weak), MOBILITY DECREASED (Legs could not carry her), SKIN DISCOLOURATION (Looks like a sunburn), RASH (Rash) and VACCINATION SITE PRURITUS (Itchy vaccine arm) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 005C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for Thyroid disorder.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced ASTHENIA (Weak), MOBILITY DECREASED (Legs could not carry her), SKIN DISCOLOURATION (Looks like a sunburn), RASH (Rash), VACCINATION SITE PRURITUS (Itchy vaccine arm), VACCINATION SITE PAIN (Pain on the injection arm), ARTHRALGIA (Painful joints) and HEADACHE (Shooting pain in head). The patient was treated with CALAMINE for Itchy, at an unspecified dose and frequency and PARACETAMOL (TYLENOL) for Pain, at an unspecified dose and frequency. At the time of the report, ASTHENIA (Weak), MOBILITY DECREASED (Legs could not carry her), SKIN DISCOLOURATION (Looks like a sunburn), RASH (Rash), VACCINATION SITE PRURITUS (Itchy vaccine arm), ARTHRALGIA (Painful joints) and HEADACHE (Shooting pain in head) outcome was unknown and VACCINATION SITE PAIN (Pain on the injection arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications include unspecified Thyroid medication  It was reported that patient felt pain is still on and off.   This case was linked to MOD-2021-222545 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Additional information was received from initial reporter: reporter mail ID was added
Sex: M
Vaccine: COVID19
Symptoms: Illness
Clinical narrative: on his 3rd sick day after 2nd shot; This spontaneous case was reported by a consumer and describes the occurrence of ILLNESS (on his 3rd sick day after 2nd shot) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced ILLNESS (on his 3rd sick day after 2nd shot). At the time of the report, ILLNESS (on his 3rd sick day after 2nd shot) outcome was unknown.            Concomitant medications were not provided. Treatment information was not reported.    This case was linked to MOD-2021-187139 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Chest pain, Dizziness, Headache
Clinical narrative: Chest pain; Dizzy; Headache; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (Chest pain), DIZZINESS (Dizzy) and HEADACHE (Headache) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (Chest pain), DIZZINESS (Dizzy) and HEADACHE (Headache). At the time of the report, CHEST PAIN (Chest pain), DIZZINESS (Dizzy) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment medications were unknown.    Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: I missed my second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (I missed my second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (I missed my second dose). At the time of the report, PRODUCT DOSE OMISSION ISSUE (I missed my second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment medication provided. No concomitant medication provided.
Sex: U
Vaccine: COVID19
Symptoms: Headache, Pyrexia
Clinical narrative: Fever keeps getting worse; Headache keeps getting worse; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever keeps getting worse) and HEADACHE (Headache keeps getting worse) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever keeps getting worse) and HEADACHE (Headache keeps getting worse). At the time of the report, PYREXIA (Fever keeps getting worse) and HEADACHE (Headache keeps getting worse) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No treatment drugs was provided. No concomitant drugs was provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Feeling hot, Pruritus, Skin mass
Clinical narrative: I've had an itchy; I've had hot red lump appear on my arm; I've had hot red lump appear on my arm; I've had lump appear on my arm; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (I've had an itchy), ERYTHEMA (I've had hot red lump appear on my arm), FEELING HOT (I've had hot red lump appear on my arm) and SKIN MASS (I've had lump appear on my arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (I've had an itchy), ERYTHEMA (I've had hot red lump appear on my arm), FEELING HOT (I've had hot red lump appear on my arm) and SKIN MASS (I've had lump appear on my arm). At the time of the report, PRURITUS (I've had an itchy), ERYTHEMA (I've had hot red lump appear on my arm), FEELING HOT (I've had hot red lump appear on my arm) and SKIN MASS (I've had lump appear on my arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No laboratory data provided by reporter. No concomitant medication provided by reporter. No treatment medication provided by reporter.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Pain in jaw
Clinical narrative: Jaw pain when chewing; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw pain when chewing) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 29-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN JAW (Jaw pain when chewing). At the time of the report, PAIN IN JAW (Jaw pain when chewing) outcome was unknown.            No concomitant medications were provided. Treatment medications were unknown.
Age: 44.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a 44-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 11-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-May-2021, SARS-CoV-2 test: positive (Positive) positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient concomitant medications was not reported. The patient is scheduled for second vaccine dose on 08-Jun-2021.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Discomfort, Disturbance in attention, Dizziness, Fatigue
Clinical narrative: All over Stiffness/Upper arm stiffness; Blurred vision/Visual changes; Could not focus on anything; Dizzy; Muscle rigidity/Joint rigidity/All over rigidity; Felt like having Mono; Felt like moving cement; Could not do anything; Pain in the arms; Achiness; Enlarged lymph nodes; Extreme fatigue; Muscle soreness; Weakness; Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness) and MYALGIA (Muscle soreness) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and VITAMIN B COMPLEX for Supplementation therapy, LAMOTRIGINE (LAMICTAL XR), METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), ETHINYLESTRADIOL, LEVONORGESTREL (JOLESSA), LACTOBACILLUS NOS (CULTURELLE), DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID]), ALPRAZOLAM (XANAX SR) and DIAZEPAM (VALIUM) for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness). On 03-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything) and DIZZINESS (Dizzy). At the time of the report, FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything), DIZZINESS (Dizzy), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   second dose was scheduled on 30 may 2021. no treatment was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Infectious mononucleosis, Lymphadenopathy, Mobility decreased, Muscle rigidity
Clinical narrative: All over Stiffness/Upper arm stiffness; Blurred vision/Visual changes; Could not focus on anything; Dizzy; Muscle rigidity/Joint rigidity/All over rigidity; Felt like having Mono; Felt like moving cement; Could not do anything; Pain in the arms; Achiness; Enlarged lymph nodes; Extreme fatigue; Muscle soreness; Weakness; Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness) and MYALGIA (Muscle soreness) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and VITAMIN B COMPLEX for Supplementation therapy, LAMOTRIGINE (LAMICTAL XR), METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), ETHINYLESTRADIOL, LEVONORGESTREL (JOLESSA), LACTOBACILLUS NOS (CULTURELLE), DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID]), ALPRAZOLAM (XANAX SR) and DIAZEPAM (VALIUM) for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness). On 03-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything) and DIZZINESS (Dizzy). At the time of the report, FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything), DIZZINESS (Dizzy), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   second dose was scheduled on 30 may 2021. no treatment was provided.
Age: 37.0
Sex: F
Vaccine: COVID19
Symptoms: Musculoskeletal stiffness, Myalgia, Pain, Pain in extremity, Vision blurred
Clinical narrative: All over Stiffness/Upper arm stiffness; Blurred vision/Visual changes; Could not focus on anything; Dizzy; Muscle rigidity/Joint rigidity/All over rigidity; Felt like having Mono; Felt like moving cement; Could not do anything; Pain in the arms; Achiness; Enlarged lymph nodes; Extreme fatigue; Muscle soreness; Weakness; Discomfort; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness) and MYALGIA (Muscle soreness) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included CALCIUM CARBONATE, COLECALCIFEROL (VITAMIN D 2000) and VITAMIN B COMPLEX for Supplementation therapy, LAMOTRIGINE (LAMICTAL XR), METHYLPHENIDATE HYDROCHLORIDE (CONCERTA), ETHINYLESTRADIOL, LEVONORGESTREL (JOLESSA), LACTOBACILLUS NOS (CULTURELLE), DOCOSAHEXAENOIC ACID, EICOSAPENTAENOIC ACID (OMEGA 3 [DOCOSAHEXAENOIC ACID;EICOSAPENTAENOIC ACID]), ALPRAZOLAM (XANAX SR) and DIAZEPAM (VALIUM) for an unknown indication.    On 02-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 02-May-2021, the patient experienced FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness). On 03-May-2021, the patient experienced MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything) and DIZZINESS (Dizzy). At the time of the report, FATIGUE (Extreme fatigue), ASTHENIA (Weakness), DISCOMFORT (Discomfort), MUSCULOSKELETAL STIFFNESS (All over Stiffness/Upper arm stiffness), MYALGIA (Muscle soreness), LYMPHADENOPATHY (Enlarged lymph nodes), VISION BLURRED (Blurred vision/Visual changes), DISTURBANCE IN ATTENTION (Could not focus on anything), DIZZINESS (Dizzy), MUSCLE RIGIDITY (Muscle rigidity/Joint rigidity/All over rigidity), INFECTIOUS MONONUCLEOSIS (Felt like having Mono), FEELING ABNORMAL (Felt like moving cement), MOBILITY DECREASED (Could not do anything), PAIN IN EXTREMITY (Pain in the arms) and PAIN (Achiness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   second dose was scheduled on 30 may 2021. no treatment was provided.
Sex: U
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: COVID-19; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID-19) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 01-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-May-2021, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-May-2021, SARS-CoV-2 test: unknown Positive.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       It was reported that the patient remained on quarantine until 18 May 2021 and was reported negative at the time of report. The second dose was scheduled on 29 May 2021. No concomitant  and treatment information was not provided. Concomitant product use was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Erythema
Clinical narrative: Erythema of extremities; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a patient and describes the occurrence of ERYTHEMA (Erythema of extremities) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was reported.     On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced ERYTHEMA (Erythema of extremities). At the time of the report, ERYTHEMA (Erythema of extremities) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided. No treatment was reported.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site pruritus
Clinical narrative: injection site supposed to itch; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (injection site supposed to itch) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (injection site supposed to itch). At the time of the report, VACCINATION SITE PRURITUS (injection site supposed to itch) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported , No treatment medication was reported .
Sex: U
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIARRHOEA (Diarrhea). At the time of the report, DIARRHOEA (Diarrhea) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication details was reported. No treatment medication details was reported.
Sex: U
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Mental fatigue, Nightmare
Clinical narrative: Having super weird dreams; Wake up sweating; Brain fog throughout the day; Feeling super off mentally; This spontaneous case was reported by a consumer and describes the occurrence of NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medication history was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally). At the time of the report, NIGHTMARE (having super weird dreams), HYPERHIDROSIS (wake up sweating), FEELING ABNORMAL (brain fog throughout the day) and MENTAL FATIGUE (Feeling super off mentally) outcome was unknown.            No treatment medication was provided. No concomitant medication was provided. Action taken with respect to mRNA-1273 was not applicable.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Skin papilloma
Clinical narrative: Bad reaction with Itching in Lower extremities; Warts; Rash in her lower legs/Rash in her arm (upper and lower); This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Bad reaction with Itching in Lower extremities), SKIN PAPILLOMA (Warts) and RASH (Rash in her lower legs/Rash in her arm (upper and lower)) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 020B21A and 024M20A) for COVID-19 vaccination.     No medical history was reported by reporter.  Concomitant products included ATORVASTATIN and CYCLOBENZAPRINE for an unknown indication.   On 10-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 07-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PRURITUS (Bad reaction with Itching in Lower extremities), SKIN PAPILLOMA (Warts) and RASH (Rash in her lower legs/Rash in her arm (upper and lower)). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at an unspecified dose and frequency; LORATADINE for Adverse event, at an unspecified dose and frequency; BETAMETHASONE for Adverse event, at an unspecified dose and frequency; METHYLPREDNISOLONE for Adverse event, at an unspecified dose and frequency; TRIAMTERENE for Adverse event, at an unspecified dose and frequency and HYDROXYZINE for Adverse event, at an unspecified dose and frequency. At the time of the report, PRURITUS (Bad reaction with Itching in Lower extremities) and SKIN PAPILLOMA (Warts) outcome was unknown and RASH (Rash in her lower legs/Rash in her arm (upper and lower)) had not resolved.            It was reported that  She has been to several doctors including a dermatologist and have been prescribed multiple medication    Most recent FOLLOW-UP information incorporated above includes: On 23-Jul-2021: Follow up received on 23-JUL-2021 contains outcome of the event rash to not recovered/ not resolved. On 27-Jul-2021: Follow up received contains No New Information
Sex: U
Vaccine: COVID19
Symptoms: Chills, Pyrexia
Clinical narrative: chills; temperature; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (chills) and PYREXIA (temperature) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHILLS (chills) and PYREXIA (temperature). At the time of the report, CHILLS (chills) and PYREXIA (temperature) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain
Clinical narrative: Abdominal pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (Abdominal pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ABDOMINAL PAIN (Abdominal pain). At the time of the report, ABDOMINAL PAIN (Abdominal pain) outcome was unknown.            No concomitant medications were reported. No treatment was reported.
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea, Hypoaesthesia, Pain, Paraesthesia, Vaccination site pain
Clinical narrative: radiated up to my entire upper shoulder for a week then it got better but then all this week I have had pain; severe pain begin at the injection site; numbness; tingling; difficulty breathing; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (difficulty breathing), PAIN (radiated up to my entire upper shoulder for a week then it got better but then all this week I have had pain), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling) and VACCINATION SITE PAIN (severe pain begin at the injection site) in an 81-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Apr-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Apr-2021, the patient experienced DYSPNOEA (difficulty breathing). On 27-May-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced HYPOAESTHESIA (numbness) and PARAESTHESIA (tingling). On an unknown date, the patient experienced PAIN (radiated up to my entire upper shoulder for a week then it got better but then all this week I have had pain) and VACCINATION SITE PAIN (severe pain begin at the injection site). At the time of the report, DYSPNOEA (difficulty breathing), PAIN (radiated up to my entire upper shoulder for a week then it got better but then all this week I have had pain), HYPOAESTHESIA (numbness), PARAESTHESIA (tingling) and VACCINATION SITE PAIN (severe pain begin at the injection site) had not resolved. Not Provided          Concomitant product use was not reported. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Inflammation, Pruritus
Clinical narrative: Itching after a week of receiving the vaccine; Inflammation after a week of receiving the vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (Itching after a week of receiving the vaccine) and INFLAMMATION (Inflammation after a week of receiving the vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (Itching after a week of receiving the vaccine) and INFLAMMATION (Inflammation after a week of receiving the vaccine). At the time of the report, PRURITUS (Itching after a week of receiving the vaccine) and INFLAMMATION (Inflammation after a week of receiving the vaccine) outcome was unknown.            No concomitant and treatment medications were reported.
Sex: U
Vaccine: COVID19
Symptoms: Hypersensitivity
Clinical narrative: Tipe of allergies; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of HYPERSENSITIVITY (Tipe of allergies) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced HYPERSENSITIVITY (Tipe of allergies). At the time of the report, HYPERSENSITIVITY (Tipe of allergies) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported by investigator  No treatment medications provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Muscle spasms, Pain in extremity
Clinical narrative: Sore arm; Muscle cramping; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and MUSCLE SPASMS (Muscle cramping) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     Concurrent medical conditions included Depression (The patient's pre-existing medical condition include anti-depressant.).    On 10-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and MUSCLE SPASMS (Muscle cramping). At the time of the report, PAIN IN EXTREMITY (Sore arm) and MUSCLE SPASMS (Muscle cramping) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Sex: U
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pruritus
Clinical narrative: Injection site is itchy; Red; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Red) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Red). At the time of the report, VACCINATION SITE PRURITUS (Injection site is itchy) and VACCINATION SITE ERYTHEMA (Red) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication was reported . No treatment medication was reported .  AE submitted via Chatbot
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Pyrexia
Clinical narrative: potential symptom of being tired; potential symptom of spent a day in bed having fever; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (potential symptom of being tired) and PYREXIA (potential symptom of spent a day in bed having fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced FATIGUE (potential symptom of being tired) and PYREXIA (potential symptom of spent a day in bed having fever). The patient was treated with IBUPROFEN (MOTRIN) at an unspecified dose and frequency. At the time of the report, FATIGUE (potential symptom of being tired) and PYREXIA (potential symptom of spent a day in bed having fever) outcome was unknown.            Relevant concomitant medications were not reported.  The action taken with mRNA-1273 in response to event was not applicable.   This case was linked to MOD-2021-186701, MOD-2021-187222, MOD-2021-186668 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Pain in jaw
Clinical narrative: Jaw pain; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN JAW (Jaw pain) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN JAW (Jaw pain). At the time of the report, PAIN IN JAW (Jaw pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication list was not provided. Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: I have a fever; This spontaneous case was reported by a patient and describes the occurrence of PYREXIA (I have a fever) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage form. On an unknown date, the patient experienced PYREXIA (I have a fever). At the time of the report, PYREXIA (I have a fever) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were provided. Treatment information were not provided.   Reporter did not allow further contact
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Axillary mass, Myalgia, Pyrexia
Clinical narrative: armpit swelled on his left arm and it is ongoing; fever; Body ache; This spontaneous case was reported by a patient and describes the occurrence of AXILLARY MASS (armpit swelled on his left arm and it is ongoing), PYREXIA (fever) and MYALGIA (Body ache) in a 50-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 04B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Apr-2021, the patient experienced AXILLARY MASS (armpit swelled on his left arm and it is ongoing), PYREXIA (fever) and MYALGIA (Body ache). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 26-Apr-2021, PYREXIA (fever) and MYALGIA (Body ache) had resolved. At the time of the report, AXILLARY MASS (armpit swelled on his left arm and it is ongoing) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Feeling abnormal, Headache, Influenza
Clinical narrative: Not feeling good; Feeling rundown; Chills; Feeling like crap, she is not feeling good, she is feeling rundown; She feels like she has the flu, but worse; So much pain that her whole body hurts; Headache that is off the charts; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts) and HEADACHE (Headache that is off the charts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bipolar disorder. Concomitant products included SELEGILINE (EMSAM) for Bipolar disorder.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts), HEADACHE (Headache that is off the charts), FATIGUE (Feeling rundown) and CHILLS (Chills). At the time of the report, MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts), HEADACHE (Headache that is off the charts), FATIGUE (Feeling rundown) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   Reporter did not allow further contact
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: Not feeling good; Feeling rundown; Chills; Feeling like crap, she is not feeling good, she is feeling rundown; She feels like she has the flu, but worse; So much pain that her whole body hurts; Headache that is off the charts; This spontaneous case was reported by a consumer and describes the occurrence of MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts) and HEADACHE (Headache that is off the charts) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Bipolar disorder. Concomitant products included SELEGILINE (EMSAM) for Bipolar disorder.    On 26-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts), HEADACHE (Headache that is off the charts), FATIGUE (Feeling rundown) and CHILLS (Chills). At the time of the report, MALAISE (Not feeling good), FEELING ABNORMAL (Feeling like crap, she is not feeling good, she is feeling rundown), INFLUENZA (She feels like she has the flu, but worse), MYALGIA (So much pain that her whole body hurts), HEADACHE (Headache that is off the charts), FATIGUE (Feeling rundown) and CHILLS (Chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not reported.   Reporter did not allow further contact
Sex: M
Vaccine: COVID19
Symptoms: Shoulder operation
Clinical narrative: Shoulder surgery; This spontaneous case was reported by a consumer and describes the occurrence of SHOULDER OPERATION (Shoulder surgery) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SHOULDER OPERATION (Shoulder surgery). At the time of the report, SHOULDER OPERATION (Shoulder surgery) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications reported. The patient wants to know will the shoulder surgery effect the second Moderna vaccine he is scheduled for on 5-28-2021. No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: dizziness; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 28-May-2021 and was forwarded to Moderna on 28-May-2021.    This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (dizziness). At the time of the report, DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment information was not provided Concomitant medication were not provided.
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Pyrexia
Clinical narrative: Fever of 101.2; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Fever of 101.2) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PYREXIA (Fever of 101.2). At the time of the report, PYREXIA (Fever of 101.2) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 101.2 (High) 101.2.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication was reported.. No Treatment information was reported.
Sex: F
Vaccine: COVID19
Symptoms: Maternal exposure during pregnancy
Clinical narrative: pregnant when she got the vaccine; This spontaneous prospective pregnancy case was reported by a consumer and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (pregnant when she got the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. Last menstrual period and estimated date of delivery were not provided. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (pregnant when she got the vaccine). The delivery occurred on an unknown date, which was reported as Unknown. For neonate 1, The outcome was reported as Unknown. At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (pregnant when she got the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not provided. Treatment information was not reported.
Sex: F
Vaccine: COVID19
Symptoms: Chills, Headache, Pain, Pain in extremity, Paraesthesia
Clinical narrative: Tingling in my hand on the same arm of the injection; sore arm; Body ache; Headache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Tingling in my hand on the same arm of the injection), PAIN IN EXTREMITY (sore arm), PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 045B21A) for COVID-19 vaccination.     No Medical History information was reported.  On 25-May-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PARAESTHESIA (Tingling in my hand on the same arm of the injection), PAIN IN EXTREMITY (sore arm), PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills). At the time of the report, PARAESTHESIA (Tingling in my hand on the same arm of the injection), PAIN (Body ache), HEADACHE (Headache) and CHILLS (Chills) outcome was unknown.      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided. No relevant concomitant medications reported.   Reporter did not allow further contact